Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $112,482 - $146,457
545 New
545 $112,000
Q2 2022

Aug 11, 2022

SELL
$204.13 - $302.4 $3.91 Million - $5.78 Million
-19,130 Reduced 73.04%
7,060 $1.51 Million
Q1 2022

May 11, 2022

BUY
$255.51 - $362.11 $4.38 Million - $6.21 Million
17,157 Added 189.94%
26,190 $7.44 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $3.37 Million - $4.14 Million
9,033 New
9,033 $3.73 Million
Q2 2021

Aug 12, 2021

SELL
$294.17 - $371.65 $153,262 - $193,629
-521 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$249.67 - $299.48 $125,584 - $150,638
503 Added 2794.44%
521 $151,000
Q4 2020

Feb 12, 2021

SELL
$222.0 - $252.62 $95,016 - $108,121
-428 Reduced 95.96%
18 $4,000
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $2.46 Million - $3.18 Million
-14,039 Reduced 96.92%
446 $101,000
Q2 2020

Aug 12, 2020

SELL
$118.84 - $189.72 $181,825 - $290,271
-1,530 Reduced 9.55%
14,485 $2.53 Million
Q1 2020

May 13, 2020

BUY
$98.9 - $178.34 $1.39 Million - $2.5 Million
14,041 Added 711.3%
16,015 $2.02 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $406,763 - $492,956
-3,227 Reduced 62.05%
1,974 $302,000
Q3 2019

Nov 12, 2019

SELL
$125.07 - $143.67 $1.26 Million - $1.45 Million
-10,059 Reduced 65.92%
5,201 $688,000
Q2 2019

Aug 12, 2019

SELL
$123.4 - $148.55 $926,980 - $1.12 Million
-7,512 Reduced 32.99%
15,260 $2.17 Million
Q1 2019

May 10, 2019

BUY
$104.82 - $146.73 $1.49 Million - $2.09 Million
14,260 Added 167.53%
22,772 $3.31 Million
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $894,526 - $1.17 Million
8,512 New
8,512 $963,000
Q3 2018

Nov 09, 2018

SELL
$112.11 - $134.54 $507,409 - $608,928
-4,526 Closed
0 $0
Q2 2018

Aug 08, 2018

BUY
$102.37 - $117.25 $463,326 - $530,673
4,526 New
4,526 $508,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.